China Drug Evaluation Report 2019 by CDE – –– Part 4. Priority Review, CDE Meetings, NMPA Inspection & Approval
In 2019, the Center for Drug Evaluation (CDE) of China reviewed and approved a total of 8730 drug registration applications. As a follow-up on part 3 of Drug Evaluation Report 2019, part 4 further gives an overview of new drug approvals for hot topics in drug therapy and major regulatory events/reforms of 2019 summarized by…
